IQV

+ Watchlist + Portfolio

IQVIA Holdings, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $249.28
52-Week Range: $154.50 – $260.26
Market Cap: $42.15B
P/E (TTM): 31.81
EPS (TTM): 8.05
Dividend Yield: —

Advanced Metrics

Price/Book: 6.83
PEG Ratio: 1.02
Return on Equity: 22.82%
Return on Assets: 5.06%
Gross Margin: 32.97%
Operating Margin: 13.03%
Profit Margin: 8.10%
Current Ratio: 0.71
Debt/Equity: 2.58
Total Debt: $16.25B
Free Cash Flow: $2.15B
Revenue Growth: 8.70%
Earnings Growth: -0.60%
Enterprise Value: $55.34B

IQV Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$14.41B	$14.98B	$15.40B	$16.31B
Cost of Revenue	$9.38B	$9.74B	$10.03B	$10.88B
Gross Profit	$5.03B	$5.24B	$5.38B	$5.43B
Selling, General & Admin	$2.07B	$2.05B	$1.99B	$2.00B
Operating Expenses	$3.20B	$3.18B	$3.11B	$3.14B
Operating Income	$1.83B	$2.06B	$2.27B	$2.29B
EBITDA	$2.91B	$3.26B	$3.45B	$3.46B
Pretax Income	$1.36B	$1.46B	$1.67B	$1.59B
Income Tax	$260.00M	$101.00M	$301.00M	$252.00M
Net Income	$1.09B	$1.36B	$1.37B	$1.36B
Diluted EPS	5.72	7.29	7.49	7.84
Diluted Shares	190.60M	186.30M	183.40M	173.50M

IQV Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.22B	$1.38B	$1.70B	$1.98B
Receivables	$2.96B	$3.41B	$3.24B	$3.43B
Current Assets	$4.98B	$5.60B	$5.83B	$6.25B
Total Assets	$25.34B	$26.68B	$26.90B	$29.94B
Current Liabilities	$5.58B	$6.49B	$6.96B	$8.34B
Long-Term Debt	$12.60B	$12.96B	$12.84B	$13.88B
Total Debt	$13.01B	$13.90B	$14.16B	—
Total Liabilities	$19.57B	$20.57B	$20.83B	$23.31B
Retained Earnings	$3.33B	$4.69B	$6.07B	$7.42B
Shareholders' Equity	$5.76B	$6.11B	$6.07B	$6.50B
Working Capital	-$597.00M	-$895.00M	-$1.13B	-$2.09B
Net Debt	$11.53B	$12.30B	$12.28B	$13.74B

IQV Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$2.26B	$2.15B	$2.72B	$2.65B
Capital Expenditure	-$674.00M	-$649.00M	-$602.00M	-$603.00M
Free Cash Flow	$1.59B	$1.50B	$2.11B	$2.05B
Depreciation & Amortisation	$1.13B	$1.13B	$1.11B	$1.14B
Stock-Based Compensation	$194.00M	$217.00M	$206.00M	$247.00M
Investing Cash Flow	-$2.01B	-$1.60B	-$1.44B	-$2.31B
Financing Cash Flow	-$329.00M	-$382.00M	-$878.00M	-$150.00M
Share Repurchases	-$1.17B	-$992.00M	-$1.35B	-$1.24B
Net Change in Cash	-$75.00M	$164.00M	$394.00M	$199.00M

IQV Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$4.02B	$4.10B	$4.36B	$4.15B	$4.37B
Cost of Revenue	$2.69B	$2.73B	$2.93B	$2.80B	$2.93B
Gross Profit	$1.32B	$1.37B	$1.44B	$1.35B	$1.44B
Selling, General & Admin	$509.00M	$514.00M	$468.00M	$502.00M	$574.00M
Operating Expenses	$785.00M	$800.00M	$785.00M	$790.00M	$866.00M
Operating Income	$538.00M	$573.00M	$651.00M	$565.00M	$569.00M
EBITDA	$781.00M	$883.00M	$1.05B	$808.00M	$790.00M
Pretax Income	$323.00M	$408.00M	$537.00M	$328.00M	$301.00M
Income Tax	$56.00M	$76.00M	$59.00M	$59.00M	$60.00M
Net Income	$266.00M	$331.00M	$514.00M	$274.00M	$256.00M
Diluted EPS	1.54	1.93	2.99	1.61	1.53
Diluted Shares	173.20M	171.70M	171.90M	169.80M	167.30M

IQV Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$2.04B	$1.81B	—	$1.95B	$1.91B
Receivables	$3.41B	$3.31B	$3.43B	$3.38B	$3.39B
Current Assets	$6.34B	$5.98B	$6.25B	$6.22B	$6.23B
Total Assets	$28.63B	$28.73B	$29.94B	$29.68B	$29.88B
Current Liabilities	$7.57B	$8.51B	—	$8.33B	$8.81B
Long-Term Debt	$14.18B	$12.79B	$13.88B	$13.99B	$13.71B
Total Debt	$15.70B	$15.19B	$15.95B	$16.07B	$16.24B
Total Liabilities	$22.85B	$22.44B	$23.31B	$23.33B	$23.58B
Retained Earnings	$6.58B	$6.91B	$7.42B	$7.70B	$7.96B
Shareholders' Equity	$5.78B	$6.16B	$6.50B	$6.22B	$6.17B
Working Capital	-$1.23B	-$2.53B	-$2.09B	-$2.11B	-$2.59B
Net Debt	$13.45B	$13.14B	$13.74B	$13.89B	$14.09B

IQV Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$443.00M	$908.00M	—	$618.00M	$558.00M
Capital Expenditure	-$151.00M	-$136.00M	-$174.00M	-$127.00M	-$198.00M
Free Cash Flow	$292.00M	$772.00M	$561.00M	$491.00M	$360.00M
Depreciation & Amortisation	$276.00M	$286.00M	$317.00M	$288.00M	$292.00M
Stock-Based Compensation	$60.00M	$55.00M	$60.00M	$65.00M	$95.00M
Investing Cash Flow	-$346.00M	-$550.00M	-$1.10B	-$196.00M	-$381.00M
Financing Cash Flow	$145.00M	-$572.00M	$535.00M	-$433.00M	-$214.00M
Share Repurchases	-$657.00M	$0.00	-$212.00M	-$552.00M	-$398.00M
Net Change in Cash	$242.00M	-$214.00M	$166.00M	-$11.00M	-$37.00M

Market Snapshot

About

IQVIA Holdings is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company combines healthcare data, domain expertise, and advanced analytics to help pharmaceutical, biotech, and medical device companies accelerate innovation and improve patient outcomes. IQVIA operates across drug development, commercialization, and real-world evidence generation, serving clients throughout the healthcare value chain. The company was formed through the merger of Quintiles and IMS Health, creating an integrated healthcare intelligence platform.